These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 24593022)
1. Malaria chemoprophylaxis with atovaquone-proguanil: is a shorter regimen fully protective? Grobusch MP J Travel Med; 2014; 21(2):79-81. PubMed ID: 24593022 [No Abstract] [Full Text] [Related]
2. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers. Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083 [TBL] [Abstract][Full Text] [Related]
3. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana. Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377 [TBL] [Abstract][Full Text] [Related]
4. Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review. Savelkoel J; Binnendijk KH; Spijker R; van Vugt M; Tan K; Hänscheid T; Schlagenhauf P; Grobusch MP Travel Med Infect Dis; 2018; 21():3-20. PubMed ID: 29242073 [TBL] [Abstract][Full Text] [Related]
5. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa. Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915 [TBL] [Abstract][Full Text] [Related]
7. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546 [TBL] [Abstract][Full Text] [Related]
8. Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Tommasi C; Bellagamba R; Tempestilli M; D'Avolio A; Gallo AL; Ivanovic J; Nicastri E; Pucillo LP; Narciso P Malar J; 2011 May; 10():141. PubMed ID: 21600016 [TBL] [Abstract][Full Text] [Related]
9. Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast. Wurtz N; Pascual A; Marin-Jauffre A; Bouchiba H; Benoit N; Desbordes M; Martelloni M; Pommier de Santi V; Richa G; Taudon N; Pradines B; Briolant S Malar J; 2012 May; 11():146. PubMed ID: 22551095 [TBL] [Abstract][Full Text] [Related]
10. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options. Meltzer E; Rahav G; Schwartz E Clin Infect Dis; 2018 May; 66(11):1751-1755. PubMed ID: 29228132 [TBL] [Abstract][Full Text] [Related]
11. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers. DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of atovaquone and proguanil hydrochloride. Beerahee M J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547 [TBL] [Abstract][Full Text] [Related]
13. Atovaquone-proguanil use in early pregnancy and the risk of birth defects. Pasternak B; Hviid A Arch Intern Med; 2011 Feb; 171(3):259-60. PubMed ID: 21325117 [No Abstract] [Full Text] [Related]
14. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine. Meltzer E; Schwartz E J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377 [No Abstract] [Full Text] [Related]
15. Atovaquone and proguanil for the treatment of malaria in Brazil. de Alencar FE; Cerutti C; Durlacher RR; Boulos M; Alves FP; Milhous W; Pang LW J Infect Dis; 1997 Jun; 175(6):1544-7. PubMed ID: 9180204 [TBL] [Abstract][Full Text] [Related]
16. The conundrum of malaria chemoprophylaxis. Shanks D J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470 [TBL] [Abstract][Full Text] [Related]
17. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment]. Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398 [No Abstract] [Full Text] [Related]
18. Malaria protection in Sierra Leone during the Ebola outbreak 2014/15; The UK military experience with malaria chemoprophylaxis Sep 14-Feb 15. Tuck J; Williams J Travel Med Infect Dis; 2016; 14(5):471-474. PubMed ID: 27474994 [TBL] [Abstract][Full Text] [Related]
19. Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions. Simons R; Valk PJ; Krul AJ J Travel Med; 2005; 12(4):210-6. PubMed ID: 16086896 [TBL] [Abstract][Full Text] [Related]
20. 39-Year-Old Woman With Headache and Fever. Matcha GV; Steele HP; Harris DM Mayo Clin Proc; 2015 Nov; 90(11):e119-23. PubMed ID: 26541259 [No Abstract] [Full Text] [Related] [Next] [New Search]